Skip to main content

JANE STREET GROUP, LLC

Position in PRME — Prime Medicine, Inc.

CIK 1595888 NEW YORK, NY

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
11 quarters on record

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Derivatives in PRME

reported options exposure · as of Jun 30, 2026
CallValue
$718,074
CallShares
194,600
PutValue
$285,606
PutShares
77,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,363,862,981 across 291 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $718,074 194,600
2026-06-30 $285,606 77,400
2026-03-31 $522,696 150,200
2026-03-31 $763,164 219,300
2025-12-31 $386,211 111,300
2025-12-31 $272,048 78,400
2025-09-30 $209,966 37,900
2025-09-30 $670,894 121,100
2025-09-30 $475,840 85,892
2025-06-30 $27,911 11,300
2025-06-30 $67,047 27,145
2024-12-31 $297,133 101,758
2024-09-30 $222,710 57,548
2024-06-30 $865,662 168,417
2024-03-31 $192,276 27,468
2023-12-31 $489,239 55,219
2023-06-30 $5,816,108 397,004